Congratulations to PhD graduates!
The EuroQol Association Group is proud to announce that 11 PhD students from EuroQol members have successfully defended their PhD theses in 2017/2018. Congratulations!
EuroQol Office team film
The EuroQol Office team is based in Rotterdam, the Netherlands, and supports the EuroQol Research Foundation, the EuroQol Group Association and its members. We recently produced a brief film on the EuroQol Office team, see below.
EQ-5D is a recommended tool for use in cost-utility analyses around the globe
A recent literature search, supplemented with information provided by EuroQol members, revealed that EQ-5D is the recommended tool for use in cost-utility analysis by a number of Health Technology Assessment bodies around the globe (including Colombia, Czech Republic, England and…
First results of United States valuation study for the EQ-5D-5L presented at ISPOR 2018
Dr A Simon Pickard has presented the first results of the US valuation study for the EQ-5D-5L at the ISPOR Conference in Baltimore, USA on Monday 21 May 2018. The project team at the University of Illinois at Chicago used…
PharmacoEconomics publishes series of articles on the EQ-5D-5L
The journal PharmacoEconomics has recently published online a series of four articles and two commentaries on the five level version of the EQ-5D (EQ-5D-5L). One article reports the first head-to-head comparison of the descriptive systems and value sets for the…
Dutch EQ-5D-5L article is the third most downloaded paper in Value in Health 2016
High levels of interest in the EQ-5D-5L are demonstrated by the article by Versteegh et al (2016), who established the Dutch tariff for the EQ-5D-5L , being third in the list of most popular downloads in Value in Health 2016.…
Is NICE ready to take EQ-5D to the next level?
At the 2017 ISPOR European Congress, a workshop was organised where representatives from the National Institute for Health and Care Excellence (NICE), the University of Sheffield, the Office of Health Economics (OHE), London and the EuroQol Research Foundation jointly presented…
NICE position statement on the EQ-5D-5L
The National Institute of Health and Care Excellence (NICE) in England has made an interim position statement about the use of the 5 level version of the EQ-5D for companies, academic groups, and others preparing evidence submissions for NICE. The…
A Lifetime of Achievement: A Profile of Paul Kind
Paul Kind, a founding member of the EuroQol Group, has won the ISPOR’s 2017 Avedis Donabedian Outcomes Research Lifetime Achievement Award. The Award recognizes an individual's outstanding, life-long achievement in the area of improving health outcomes. Paul is known for…
‘Extending the QALY’ project collaboration with NICE
NICE is taking part in a project that will examine how quality of life measures used to evaluate healthcare treatments such as drugs can be extended into areas of social care and public health. The research is being led by…